Dual-phase 99mTc-MIBI scintigraphy to assess calcimimetic effect in patients on haemodialysis with secondary hyperparathyroidism

Nuclear Medicine Communications

Volumn 30, Issue 11, 2009, Pages 890-894

  Fuster, David ^a,d   Torregrosab, José Vicente ^b   Domenecha, Beatriz ^a   Solà, Oriol ^a   Martínc, Gloria ^c   Casellasc, Joan ^c   Setoain, Xavier ^a,d   Muxí, Africa ^a,d   Pons, Francesca ^a,d  

^a HOSPITAL CLÍNIC   (Spain)

^b Hospital Clinic   (Spain)

^c University of Barcelona ^*  (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

99mTc Methoxy Isobutyl Isonitrile; Calcimimetics; Imaging; Parathyroid glands; Secondary hyperparathyroidism

Indexed keywords

CINACALCET; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; CALCIMIMETIC AGENT; DIAGNOSTIC AGENT; NAPHTHALENE DERIVATIVE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DOSE INCREASE; DRUG UPTAKE; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; MALE; PARATHYROID GLAND; PARATHYROID SCINTISCANNING; SECONDARY HYPERPARATHYROIDISM; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; DRUG EFFECT; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY; SCINTISCANNING; TRANSPORT AT THE CELLULAR LEVEL; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL TRANSPORT; CALCIMIMETIC AGENTS; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROID GLANDS; RENAL DIALYSIS; TECHNETIUM TC 99M SESTAMIBI; TREATMENT OUTCOME;

EID: 73249141376     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283305df6     Document Type: Article

References (27)

1. Poon G. Cinacalcet hydrochloride (Sensipar). BUMC proceedings 2005; 18:181-184.
2. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. New Engl J Med 2004; 350:1516-1525.
3. Meola M, Petrucci I, Barsotti G. Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism. Nephrol Dial Transplant 2009; 24:707-709.
4. Piga M, Bolasco P, Satta L, Altieri P, Loi G, Nicolosi A, et al. Double-phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism. J Nucl Med 1996; 37:565-569.
5. Ambrosoni P, Olaizola I, Heuguerot C, Parodi MN, Caorsi H, Caputti S, et al. The role of imaging techniques in the study of renal osteodystrophy. Am J Med Sci 2000; 320:90-95.
6. Torregrosa JV, Palomar MR, Pons F, Sabater L, Gilabert R, Llovera J, et al. Has double-phase MIBI scintigraphy usefulness in the diagnosis of hyperparathyroidism? Nephrol Dial Transpl 1998; 13:37-40.
7. Gofrit ON, Lebensart PD, Pikarsky A, Lackstein D, Gross DJ, Shiloni E. High-resolution ultrasonography: highly sensitive, specific technique for preoperative localization of parathyroid adenoma in the absence of multinodular thyroid disease. World J Surg 1997; 21:287-291.
8. Proye CA, Carnaille B, Bizard JP, Quievreux JL, Lecomte-Houcke M. Multiglandular disease in seemingly sporadic primary hyperparathyroidism revisited: where are we in the early 1990S. A plea against unilateral parathyroid exploration. Surgery 1992; 112:1118-1122.
9. Pons F, Torregrosa JV, Vidal-Sicart S, Sabater L, Fuster D, Fernandez-Cruz L, et al. Preoperative parathyroid gland localization with technetium-99m sestamibi in secondary hyperparathyroidism. Eur J Nucl Med 1997; 24:1494-1498.
10. Ishibashi M, Nishida H, Okuda S, Suekane S, Hayabuchi N. Localization of parathyroid glands in hemodialysis patients using Tc-99m sestamibi imaging. Nephron 1998; 78:48-53.
11. Kasai ET, da Silva JW, Mandarim de Lacerda CA, Boasquevisque E. Parathyroid glands: combination of sestamibi-(99m)Tc scintigraphy and ultrasonography for demonstration of hyperplasic parathyroid glands. Rev Esp Med Nucl 2008; 27:8-12.
12. 99mTc-MIBI and neck ultrasound in secondary hyperparathyroidism patients candidate for subtotal parathyroidectomy. Eur J Nucl Med Mol Imaging 2006; 33:467-473.
13. Ugur O, Bozkurt MF, Rubello D. Nuclear medicine techniques for radio-guided surgery of hyperparathyroidism. Minerva Endocrinol 2008; 33:95-104.
14. 99mTc-Sestamibi scintigraphy in chronic haemodialysis patients: correlation with biochemical markers of parathyroid function. Nucl Med Commun 2003; 24:85-90.
15. Olaizola I, Aznarez A, Jorgetti V, Petraglia A, Caorsi H, Acuna G, et al. Are there any differences in the parathyroid response in the different types of renal osteodystrophy? Nephrol Dial Transplant 1998; 13 (Suppl 3):15-18.
16. 99mTc-sestamibi scintigraphy. Am J Kidney Dis 2004; 44:476-480.
17. Rubello D, Casara D, Giannini S, Piotto A, De Carlo E, Muzzio PC, et al. Importance of radio-guided minimally invasive parathyroidectomy using hand-held gamma probe and low (99m)Tc-MIBI dose. Technical considerations and long-term clinical results. Q J Nucl Med 2003; 47:129-138.
18. Spanu A, Falchi A, Manca A, Marongiu P, Cossu A, Pisu N, et al. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism. J Nucl Med 2004; 45:40-48.
19. Hindie E, Urena P, Jeanguillaume C, Melliere D, Berthelot JM, Menoyo-Calonge V, et al. Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet 1999; 353:2200-2204.
20. Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P. Incremental diagnostic value of preoperative Tc-99m-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 2003; 44:904-908.
21. Rubello D, Gross MD, Mariani G, AL-Nahhas A. Scintigraphic techniques in primary hyperparathyroidism: from pre-operative localisation to intraoperative imaging. Eur J Nucl Med Mol Imaging 2007; 34:926-933.
22. 4/MIBI) in primary hyperparathyroidism. Minerva Endocrinol 2001; 26:13-21.
23. Serra A, Bolasco P, Satta L, Nicolosi A, Uccheddu A, Piga M. Role of SPECT/CT in the preoperative assessment of hyperparathyroid patients. Radiol Med 2006; 111:999-1008.
24. Gotthardt M, Lohmann B, Behr TM, Bauhofer A, Franzius C, Schipper ML, et al. Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature. World J Surg 2004; 28:100-107.
25. Caixà s A, Bernà L, Hernández A, Té bar FJ, Madariaga P, Vegazo O, et al. Efficacy of preoperative diagnostic imaging localization of technetium 99m-sestamibi scintigraphy in hyperparathyroidism. Surgery 1997; 121:535-541.
26. Sofferman RA, Nathan MH. The ectopic parathyroid adenoma: a cost justification for routine pre-operative localization with technetium- 99msestamibi scan. Arch Otolaryngol Head Neck Surg 1998; 124:649-654.
27. Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med 2005; 35:266-276